While in viral infection the role of APOBEC3A is based on the innate immune response and mutations in the viral genome that inhibits their replication, in cancers, APOBEC is the cause of their mutations, the heterogeneity and diversity of tumours, and drug resistance [73]. The gene discussed is APOBEC3A; the disease is cancer.